Création d’une biobanque nationale pour l’étude des maladies trophoblastiques gestationnelles-Reference-Cited by-同舟云学术

Création d’une biobanque nationale pour l’étude des maladies trophoblastiques gestationnelles

Published:2016-06 Issue:6 Volume:45 Page:559-562
ISSN:0368-2315
Container-title:Journal de Gynécologie Obstétrique et Biologie de la Reproduction
language:fr
Short-container-title:Journal de Gynécologie Obstétrique et Biologie de la Reproduction

Author:

Bolze P.-A.,Massardier J.,Buénerd A.,Thivolet Béjui F.,Perrin C.,Rouvet I.,Sanlaville D.,Mazé M.-C.,Dufay N.,Gaucherand P.,Chêne G.,Hajri T.,Golfier F.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine,General Medicine

Reference10 articles.

1. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole;Lurain;Am J Obstet Gynecol,2010

2. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia;Lurain;Am J Obstet Gynecol,2011

3. Contribution of referent pathologists to the quality of trophoblastic diseases diagnosis;Golfier;Hum Reprod,2011

4. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis;Alifrangis;J Clin Oncol,2013

5. Optimising sample collection for placental research;Burton;Placenta,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enfermedades trofoblásticas gestacionales: molas hidatiformes;EMC - Ginecología-Obstetricia;2024-09

2. Expert Pathology for Gestational Trophoblastic Disease: Towards an International Multidisciplinary Team Meeting;Gynecologic and Obstetric Investigation;2024

3. Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma;Biomedicines;2021-10-14

4. NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive Microenvironment;Cancers;2021-06-15

5. Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy;Gynecologic Oncology;2020-09